Saikosaponin‐D induces the pyroptosis of lung cancer by increasing ROS and activating the NF‐κB/NLRP3/caspase‐1/GSDMD pathway
Journal of Biochemical and Molecular Toxicology · 2023-08 · 37 (8)
DOI: 10.1002/jbt.23444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 02.07.2023. Verfasst von Mengqing Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Southwest Medical University, Sichuan, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Saikosaponin‐D (SSD), an active ingredient in Bupleurum chinense , exerts anticancer effects in various cancers by inhibiting cancer proliferation and inducing apoptosis. However, whether SSD can induce other forms of cell death is unknown. The current study aims to demonstrate that SSD can induce pyroptosis in non‐small‐cell lung cancer. In this study, HCC827 and A549 non‐small‐cell lung cancer cells were treated with different concentrations of SSD for 1.5 h. HE and TUNEL staining were used to verify cell damage caused by SSD. Immunofluorescence and western blotting were performed to verify the effect of SSD on the NF‐κB/NLRP3/caspase‐1/gasdermin D (GSDMD) pathway. Changes in inflammatory factors were detected by ELISAs. Finally, the reactive oxygen species (ROS) scavenger N‐acetylcysteine (NAC) was introduced to verify that SSD induces pyroptosis through the ROS/NF‐κB pathway. The results of the HE and TUNEL staining showed that SSD resulted in balloon‐like swelling of NSCLC cells accompanied by increased DNA damage. Immunofluorescence and western blot assays confirmed that SSD treatment activated the NLRP3/caspase‐1/GSDMD pathway, stimulated an increase in ROS levels and activated NF‐κB in lung cancer cells. The ROS scavenger N‐acetylcysteine significantly attenuated SSD‐induced NF‐κB/NLRP3/caspase‐1/GSDMD pathway activation and inhibited the release of the inflammatory cytokines IL‐1β and IL‐18. In conclusion, SSD induced lung cancer cell pyroptosis by inducing ROS accumulation and activating the NF‐κB/NLRP3/caspase‐1/GSDMD pathway. These experiments lay the foundation for the application of SSD in the treatment of non‐small‐cell lung cancer and regulation of the lung cancer immune microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Southwest Medical University, Sichuan, China.
- Department of Respiratory and Critical Care Medicine, The First People's Hospital of Neijiang, Sichuan, China.
- Department of Pathology, The Affiliated Hospital of Southwest Medical University, Sichuan, China.
Zitieren
APA
Chen, M., Hu, C., Yang, L., Guo, Q., Liang, Y., & Wang, W. (2023). Saikosaponin‐D induces the pyroptosis of lung cancer by increasing ROS and activating the NF‐κB/NLRP3/caspase‐1/GSDMD pathway. Journal of Biochemical and Molecular Toxicology, 37(8). https://doi.org/10.1002/jbt.23444
Vancouver
Chen M, Hu C, Yang L, Guo Q, Liang Y, Wang W. Saikosaponin‐D induces the pyroptosis of lung cancer by increasing ROS and activating the NF‐κB/NLRP3/caspase‐1/GSDMD pathway. Journal of Biochemical and Molecular Toxicology. 2023;37(8). doi:10.1002/jbt.23444
BibTeX
@article{Chen2023,
author = {Chen, Mengqing and Hu, Chunyan and Yang, Lei and Guo, Qingxi and Liang, Yuling and Wang, Wenjun},
title = {Saikosaponin‐D induces the pyroptosis of lung cancer by increasing ROS and activating the NF‐κB/NLRP3/caspase‐1/GSDMD pathway},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2023},
volume = {37},
number = {8},
doi = {10.1002/jbt.23444}
}
EUVIMED